SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002008861-24-000030
Filing Date
2024-11-05
Accepted
2024-11-05 13:23:54
Documents
126
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ndoi-20240930.htm   iXBRL 10-Q 3244200
2 EX-31.1 a20240930ex311ceo302cert.htm EX-31.1 8192
3 EX-31.2 a20240930ex312cfo302cert.htm EX-31.2 8217
4 EX-32.1 a20240930ex321ceo906cert.htm EX-32.1 6047
5 EX-32.2 a20240930ex322cfo906cert.htm EX-32.2 6057
  Complete submission text file 0002008861-24-000030.txt   17400342

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ndoi-20240930.xsd EX-101.SCH 117877
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ndoi-20240930_cal.xml EX-101.CAL 104378
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ndoi-20240930_def.xml EX-101.DEF 759188
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ndoi-20240930_lab.xml EX-101.LAB 1085334
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ndoi-20240930_pre.xml EX-101.PRE 945909
128 EXTRACTED XBRL INSTANCE DOCUMENT ndoi-20240930_htm.xml XML 3024830
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

IRS No.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-280767 | Film No.: 241426712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)